ProsTIC's world leading research in the news.
3-year update from the TheraP trial
See this article published in ASCO daily news: Lu-177 Vipivotide Tetraxetan Yields Similar OS Versus Cabazitaxel in mCRPC Progressing After Docetaxel
Aussie researchers begin ‘world-first’ clinical trial
See this article on the EVOLUTION Phase II clinical trial to evaluate the effectiveness of experimental therapy combined with immunotherapy in patients with prostate cancer.
New technique to diagnose prostate cancer
See video and article how prostate cancer experts have revealed they can improve diagnosis through sophisticated imaging techniques instead of invasive biopsies.
Dr Renu Eapen presents "Best of Surgical Journals" @ ASCO GU 22
ASCO GU22 | Imaging Biomarkers analysis from the TheraP trial
#EANM21 - Prostate Cancer Along the Yellow Brick Road
Plenary | Role of PSMA PET/CT for de novo vs recurrent disease
TheraP ASCO GU presentation
TheraP data further support LuPSMA for mCRPC
Prof Michael Hofman talks to Nine News
House of Wellness Program - Channel 7
Articles:
- published 12 February 2021
Professor Michael Hofman features in this fascinating discussion on ABC Nighlife's Audit on Cancer (from 32:43). The program explores advances in cancer detection and treatment in Australia and across the globe.
Listen to Professor Michael Hofman being interviewed on The Chris Smith Show - 2GB.
World-first prostate cancer treatment trialled - Nine News Australia
Molecular imaging could transform management of people with aggressive cancer - Peter Mac News
Prostate Cancer's New Standard of Care - Australian Financial Review
Movember Story - Prostate cancer study could transform management of patients with aggressive cancer
New Radioactive treatment for advanced prostate cancer recieves big funding boost - Peter Mac News
New $5.4 M alliance to tackle prostate cancer - The University of Melbourne
Going nuclear to combat aggressive prostate cancer - Peter Mac News
'Billion-dollar molecule' may extend life in men with prostate cancer - Australian Financial Review
From Lucas Heights to PeterMac, new prostate therapy is a game-changer - Sydney Morning Herald
SNNMI Image of the Year
More places may open for 'game-changing' nuclear treatment for prostate cancer - Australian Financial Review
